A comparison of infections and complications in central venous catheters in adults with solid tumours

Journal of Vascular Access

Volumn 16, Issue 1, 2015, Pages 38-41

  Coady, Karin ^a   Ali, Mohammed ^b   Sidloff, David ^b   Kenningham, Richard R ^a   Ahmed, Samreen ^a  

^a Department of Dermatology   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Central venous catheters; Chemotherapy; Complications; Infections

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CATHETER MIGRATION; CATHETER OCCLUSION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHEMOTHERAPY; EROSION; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION RATE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; SOLID TUMOR; TUNNELLED CUFFED SILICONE CATHETER; ADVERSE EFFECTS; CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; DEVICE REMOVAL; DEVICES; EQUIPMENT DESIGN; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; TIME; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; DEVICE REMOVAL; ENGLAND; EQUIPMENT DESIGN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928167785     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000300     Document Type: Article

References (9)

1. Galloway M. Insertion and placement of central catheters in the oncology patient. Semin Oncol Nurs. 2010;26(2):102-112.
2. Lyon SM, Given M, Marshall NL. Interventional radiology in the provision and maintenance of long-term central venous access. J Med Imaging Radiat Oncol. 2008;52(1):10-17.
3. Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(10): 1357-1370.
4. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: National evidence- based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65 (Suppl 1):S1-S64.
5. O'Grady NP, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4)(Suppl 1):S1-S34.
6. O'Grady N, Alexander M, Burns L, et al. 2011 guidelines for the prevention of intravascular catheter-related infections. Available at: www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html Accessed January 4, 2014.
7. Lu SF, Chen JH, Shang WM, Chou SS. [Prevention and nursing care of central line-associated bloodstream infections in critically ill patients]. Hu Li Za Zhi. 2012;59(4):5-11.
8. Alexander N. Question 3. Do Portacaths or Hickman lines have a higher risk of catheter-related bloodstream infections in children with leukaemia? Arch Dis Child. 2010;95(3):239-241.
9. Ng F, Mastoroudes H, Paul E, et al. A comparison of Hickman line-and Port-a-caths-associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol). 2007;19(7):551-556.